• 제목/요약/키워드: Rheumatoid arthritis women

검색결과 49건 처리시간 0.028초

만성통증환자의 생활경험에 관한 연구-여성 류마티스관절염 환자를 중심으로- (An Exploration of the Life Experiences of Patients with Chronic Pain : Women with Rheumatoid Arthritis)

  • 허혜경
    • 대한간호학회지
    • /
    • 제27권1호
    • /
    • pp.13-25
    • /
    • 1997
  • Rheumatoid Arthritis(RA), a chronic and systemic inflammatory disorder, is characterized by joint pain, swelling and stiffness. Patients with RA suffer from joint pain and overall pain. The painful and disabling consequences of RA are accompanied by a variety of affective, cognitive, and behavioral changes. The purpose of this paper was to explore and describe the life experiences of RA patients by eliciting verbal description of their experiences. Participants were nine persons who were diagnosed with RA, and had had it for more than six months. They were asked open ended and descriptive questions in order for them to talk about their experiences in their on terms. Interviews were tape recorded and transcribed verbatim. The transcripts were analyzed by Colaizzi method. From the protocols, 213 significant statements about life experience were organized into 83 formulating meanings which were then grouped into five theme clusters. The major themes that emgerged from the analysis were' Emotional Disturbances', 'Trying to Adapt to the Progress of Disease', 'Progress of Treatment'. 'Change of Role Performances', 'Experiences related to Family'. The result of this study showed that RA patients and families need nursing care based on a deep understanding of their lived experiences in everyday life. Nurses and other health workers must develop rehabilitation programs that focus on the pain control, functional independence and psychosocial factors.

  • PDF

류마티스관절염 환자의 심혈관 질환 및 당뇨병 위험분석: a propensity score analysis (The Risk of Cardiovascular Disease and Diabetes in Rheumatoid Arthritis Patients: A Propensity Score Analysis)

  • 유기연
    • 한국임상약학회지
    • /
    • 제29권2호
    • /
    • pp.109-114
    • /
    • 2019
  • Background: Rheumatoid arthritis (RA) is a systemic inflammatory disease that manifests as joint damage or athletic disability via sustained inflammation of the synovial membrane. The risk of cardiovascular disease (CVD) is higher in RA patients. This study aimed at evaluating the association between CVD comorbidities and RA by comparing a pharmacotherapy group with a non-pharmacotherapy group. Methods: Patient sample data from the Health Insurance Review and Assessment Service (HIRA-NPS-2016) were used. Inverse probability of treatment weighting (IPTW) using the propensity score was used to minimize the differences in patient characteristics. Logistic regression analysis was used to evaluate the risk of CVD comorbidities. Results: The analyses included 1,207,213 patients, of which 33,122 (2.8%) had RA. The odds ratios (OR) of CVD comorbidities were increased in RA patients; ischemic heart disease (IHD: OR 1.75; 95% CI 1.73, 1.77), cerebral infarction (CERI: OR 1.28; 95% CI 1.26, 1.30), hypertension (HTN: OR 1.44; 95% CI 1.43, 1.45), diabetes mellitus (DM: OR 2.04; 95% CI 2.03, 2.06), and dyslipidemia (DL: OR 3.49; 95% CI 3.47, 3.51). The ORs of IHD, CERI, HTN, and DM in the traditional DMARD and biologic treatment groups were decreased, compared with those in the non-pharmacotherapy group. Conclusions: Thus, CVD risk was higher in RA patients, considering age, sex, and socioeconomic status. Appropriate pharmacotherapy could decrease the risk of CVD comorbidities in RA patients.

메토트렉세이트 치료에 실패한 류마티스관절염 환자에서 에타너셉트 사용에 대한 비용-효과 분석 (Cost-Effectiveness Analysis of Etanercept in the Treatment of Methotrexate-resistant Rheumatoid Arthritis)

  • 김종주;박은자;박세정;성윤경;배상철;이의경
    • 약학회지
    • /
    • 제50권2호
    • /
    • pp.70-77
    • /
    • 2006
  • A cost effective analysis was performed for comparing leflunomide+methotrexate, etanercept monotherapy and etanercept+methotrexate for 6 months. For the patients with methotrexate-resistant RA, ACR20 data were extracted from the published clinical trials searched from Pubmed. The direct medical cost was estimated based on ACR guideline and Korean National Health Insurance reimbursement. Combination therapy of etanercept+methotrexate was found to be more cost-effective than etanercept monotherapy, which meant it was a better therapeutic strategy for methotrexate- resistant RA.

류마티스 관절염.루프스.섬유조직염 환자의 피로 양상 비교 (The Comparison of Fatigue of the Patients with Rheumatoid Arthritis, Lupus, and Fibromyalgia)

  • 이경숙;송경자;이은옥
    • 근관절건강학회지
    • /
    • 제7권1호
    • /
    • pp.131-147
    • /
    • 2000
  • Almost all patients with rheumatic disease experience fatigue. The fatigue affects the patient's life extensively at home and at work, therefore it is necessary to investigate the nature of the fatigue which the patients perceive. The purpose of this study is to explore the nature and pattern of fatigue of the patients with rheumatic diseases. Rheumatoid arthritis is typical disease for its joint involvement which leads to deformity. Whereas lupus is a characteristic systemic autoimmune disease and the fibromyalgia is characterized by the general bodyache and multiple local tenderness. The prevalence of these diseases and the fatigue was known to be higher in women than men. Therefore the subjects were woman patient diagnosed as rheumatoid arthritis, lupus or fibromyalgia, and they were recruited from the H-Rheumatic Disease Hospital. The two instruments, the Multidimensional Assessment of Fatigue by Belza(1995) and the Piper Fatigue Scale by Piper, et al(1995) were used to explore the nature and pattern of self-reported fatigue. In total, the data from 157 patients were analysed by the SPSS-PC program for statistical analysis. The results were as follows: 1. Most patients with rheumatic disease experienced fatigue and the degree of fatigue was at the middle range by the scores of the two instruments. 2. The degree of fatigue of the patients with fibromyalgia was the highest and the next was that of the patients with lupus and the fatigue of the patients with rheumatoid arthritis. But there were no statistically significant differences among the patients with three rheumatic diseases, except the subcategory, the meaning of fatigue of the Piper Fatigue Scale. 3. Even when the period of the symptom and pain were covariated, there were no statistically significant differences among patients with three rheumatic diseases. The fatigue of the patients with lupus and fibromyalgia is rarely investigated in Korea and this study can be the base for the further understanding of the patients with rheumatic diseases. Therefore repeated studies are required to identify the factors to affect the fatigue and to understanding the nature of the diseases and to develop the nursing interventions to alleviate the fatigue.

  • PDF

류마티스 관절염환자에서 견관절의 관절경적 활액막절제술 (Arthroscopic Synovectomy of the Shoulder Joint for Rheumatoid Arthritis)

  • 김경택;이명진;김욱
    • 대한관절경학회지
    • /
    • 제7권1호
    • /
    • pp.76-80
    • /
    • 2003
  • 목적 : 류마티스 관절염 환자에서 견관절의 관절경적 활액막 절제술에 따른 임상결과를 평가하고자 한다. 대상 및 방법 : 1998년 5월부터 2000년 2월까지 견관절에 이환된 류마티스 관절염 환자로 관절경적 활액막 절제술을 시행 받은 16례를 대상으로 하였으며 평균 추시 기간은 29개월이었다. 성별은 남자 2명, 여자 14명이었고 연령 분포는 최소 32세에서 최고 66세로 평균 50세 였다. 결과의 평가는 일본 정형외과 학회에서 제시한 견관절 수술에 따른 임상 평가 (Clinical assessment of the shoulder surgery classification system)와 환자의 주관적 만족도에 따라 만족, 양호, 불만족으로 구분하여 평가하였다. 결과 : 일본 정형외과 학회에서 제시한 견관절 수술에 따른 임상 평가에 따라 술전 관절 운동 범위의 평균점수는 13.9에서 술후 평균 23.8로 증가하였고 동통은 술전 22.0게서 술후 26.5로 증가하였다. 주관적 만족도는 만족이 7례, 양호가 7례, 불만족이 2례로 양호 이상이 14례$(88\%)$로 나타났다. 결론 : 견관절의 류마티스 관절염환자에서 관절경적 활액막 절제술을 시행하는 경우 이환 기간이 짧을수록 경도의 관절 연골의 손상인 경우 더 나은 결과를 기대할 수 있었다.

  • PDF

류마티스 관절염환자에서 Tc-99m MIBI 영상의 유용성 평가 (Evaluation of Patients with Rheumatoid Arthritis by Tc-99m MIBI Imaging)

  • 조인호;천경아;홍영훈;이충기;하정희
    • 대한핵의학회지
    • /
    • 제38권6호
    • /
    • pp.506-510
    • /
    • 2004
  • 목적: Tc-99m MIBI 을 이용하여 류마티스관절염의 치료에 대한 약제반응을 알 수 있는지를 조사하였다. 대상 및 방법: Disease modifying antirheumatic drugs(DMARDs) 병합요법으로 치료를 시행하고 3개월 후에 추적관찰이 가능하였던 24명의 류마티스 관절염환자 환자들(여자 15명, 남자 9명, 평균연령: $49{\pm}12$)을 대상으로 하여, 치료 전 적혈구침강속도와 C-반응성단백질의 수치를 조사하고, Tc-99m MIBI 스캔을 얻어서, 치료전후 압통과 부종으로 임상증상의 호전정도를 조사하여 서로 비교하였다. Tc-99m MIBI스캔에서 병적관절의 활막 대 배후 방사능비 (J/B ratio)와 함께 Tc-99m MIBI의 저류율(%R)을 구하였다. 결과: Tc-99m MIBI의 3분, 10분, 180분의 활막 대 배후 방사능비는 혈구침강속도와 C-반응성단백질의 수치와 양의 상관관계를 보여 주었다. 관절의 압통과 부종의 정도를 점수화하여 평가된 임상증상의 호전정도와 3분과 180분사이와 10분과 180분사이의 저류율 각각의 상관계수가 -0.72와 -0.76으로 유의한 음의 상관관계를 나타내었다. 결론: Tc-99m MIBI가 류마티스 관절염의 약제 치료효과평가 및 관절염의 정도를 예측할 수 있는 영상방법의 가능성을 보여 주었지만, 이의 확립을 위해서는 추가적인 연구가 필요할 것으로 사료된다.

Ginkgo Terpene의 Candidate albicans로 인한 관절염에 대한 치료효과 (Therapeutic Anti-inflammatory Effect of Ginkgo Terpene on Arthritis due to Candida albicans)

  • 이순현;이주희;한용문
    • 약학회지
    • /
    • 제49권2호
    • /
    • pp.140-146
    • /
    • 2005
  • Candida albicans, a polymorphic fungus, causes systemic and local infections. Recent reports show that the fungus is a main etiological agent for the arthritis. For trea tment, antifungal drugs and/or rheumatoid drugs are used, but resistance and side effects limit application of the drugs. In search of new sources for treatment of the fungal arthritis, we choose Egb 761 (extract of Ginkgo leaves 761), one of the most popular over-the-counter herbal medicines. The Egb 761 contains two major ingredients such as terpene and flavonoid. In the present study, we examined if the terpene portion of Egb 761 had anti-inflammatory activity against C.albicans-caused arthritis. The terpene was extracted with combination of methanol and water from the Egb 761, followed by gel-permeation chromatography. Presence of terpene was determined by the Salkowski colorimetric method and HPLC analysis. For an animal model of inflammation induction, mice were given an emulsion form of C.albicans cell wall mixed with Complete Freund's Adjuvant (CFA) by footpad-injection. Results showed that intraperitoneal administration of the water-soluble portion that contained terpene and flavonoid reduced the inflammation. Whereas the terpene had anti-inflammatory activity, flavonoid portion had no such activity, For determination of possible mechanism of the activity, the terpene seemed to be suppression of nitric oxide (NO) production from LPS-treated macrophages. Taken together the Ginkgo terpene may have anti-inflammatory effect against C.albicans-caused arthritis, possibly by blocking NO production.

여성 류마티스 관절염 환자의 건강관련 삶의 질 구조모형 (Health-related quality of life in female patients with reumatoid arthritis: a structural equation model)

  • 김부경;성미혜
    • 여성건강간호학회지
    • /
    • 제29권2호
    • /
    • pp.91-103
    • /
    • 2023
  • Purpose: This study aimed to construct a structural equation model to explain and predict factors affecting the health-related quality of life (QoL) in female rheumatoid arthritis (RA) patients based on the health-related QoL model by Ferrans et al. (2005) and a literature review. Methods: Patients (N=243) who were either registered members of an internet cafe composed of patients with RA or rheumatology outpatients at two tertiary general hospitals in Busan, Korea, were recruited via convenience sampling. Data were collected from July 2 to September 9, 2021, and the survey was conducted using a web-based questionnaire. The data were analyzed by SPSS and AMOS 26.0. Results: The goodness-of-fit statistics of the final model exhibited good results (χ2/degree of freedom=2.68, Turker-Lewis index=.94, comparative fit index=.96, standardized root mean-squared residual=.04, root mean- square error of approximation=.08), and 11 out of 14 paths of the model were supported. The squared multiple correlation, which reflected the explanatory power of the environmental characteristics, symptoms, functional status, and perceived health status on health-related QoL, was 80%. In the hypothesis model, 10 paths had significant direct effects, 6 paths had significant indirect effects, and 12 paths had significant total (direct and indirect) effects. Conclusion: Considering that factors directly affecting the health-related QoL of female patients with RA were social support, symptoms (fatigue and depression), resilience, and perceived health status, and that resilience was the most influential factor, clinicians can encourage resilience. Hence, to improve the health-related QoL of female patients with RA, continuing management is necessary, using various intervention methods that focus on enhancing resilience from the early stage to the end of treatment for RA.